Ahmet Taha Şahin

Dr. Ahmet Taha Şahin

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2025 in Biomarkers in Medicine
Verified
Journal Article
Closed access
HEHatice Eyiol
Hatice Eyiol
AEAzmi Eyiol
Azmi Eyiol
AŞAhmet Taha Şahin
Ahmet Taha Şahin
This study evaluated the Hemoglobin to Red Cell Distribution Width Ratio (HRR) and Red Cell Distribution Width to Albumin Ratio (RAR) in acute pericarditis patients, exploring associations with clinical parameters. A retrospective cohort study included 257 patients diagnosed with acute pericarditis (2015-2023). Data on hemoglobin, RDW, albumin, treatments, hospital stay, and recurrence were analyzed using SPSS 27.0. The mean age was 41 years. HRR averaged 1.067 ± 0.142, and RAR was 0.311. Men had higher hemoglobin and albumin levels, while women had higher platelet and HDL levels. Lower HRR correlated with severe conditions and recurrence, while higher RAR was linked to disease severity and recurrence. Both markers were strongly associated with pericardial effusion and IV steroid need. HRR and RAR are valuable biomarkers in acute pericarditis, aiding in assessing disease severity and guiding treatment.

1 November 2024 in International Journal of General Medicine
Verified
Journal Article
Open access
PDF file
AEAzmi Eyiol
Azmi Eyiol
HEHatice Eyiol
Hatice Eyiol
AŞAhmet Taha Şahin
Ahmet Taha Şahin
Aim: This study investigates the prognostic value of the Hemoglobin/Red Blood Cell Distribution Width Ratio (HRR) and the Red Blood Cell Distribution Width/Albumin Ratio (RAR) in patients with myocarditis. We aimed to evaluate how these novel biomarkers correlate with clinical parameters, disease severity, and outcomes. Methods: A retrospective analysis was conducted on 301 patients diagnosed with myocarditis between January 2020 and March 2024. Inclusion criteria were adults with confirmed myocarditis based on clinical, ECG and echocardiographic evaluations. Exclusion criteria included incomplete records and prior immunosuppressive therapy. We assessed various blood parameters, including HRR and RAR, and analyzed their associations with clinical outcomes, hospital stay duration, and complications. Results: The study found that HRR and RAR were significantly associated with several clinical outcomes in myocarditis patients. Higher HRR values correlated with improved outcomes, while higher RAR values were linked to worse outcomes. HRR was associated with pericardial effusion, inotropic support, and other parameters, while RAR was correlated with similar factors, including recent gastroenteritis. Patients with longer hospital stays exhibited higher inflammation markers and lower ejection fractions, underscoring the severity of their condition. Conclusion: HRR and RAR are promising biomarkers for assessing disease severity and prognosis in myocarditis. They provide additional prognostic information beyond traditional markers such as troponin and CRP, potentially guiding more personalized treatment strategies.

28 June 2024 in Cureus
Verified
Journal Article
Open access
MEMustafa C Ergun
Mustafa C Ergun
EAEda Aktas
Eda Aktas
AŞAhmet Taha Şahin
Ahmet Taha Şahin
MIMehmet Sinan İyIsoy
Mehmet Sinan İyIsoy
YAYakup Alsancak
Yakup Alsancak
RTRecep Tunc
Recep Tunc
Background Systemic lupus erythematosus (SLE) is a complex autoimmune disease with varied clinical manifestations affecting multiple organ systems. This study aimed to investigate the association between the systemic immune-inflammation index (SII) and disease activity, as well as proteinuria levels in patients with SLE. Methodology A total of 141 patients diagnosed with SLE and 99 control subjects were included in this retrospective study. SLE patients were divided into two groups based on the presence (52) or absence (89) of proteinuria. Demographic data, laboratory parameters, and disease activity scores were recorded. SII was calculated based on peripheral blood counts. Statistical analysis was performed to assess the relationship between SII levels and disease activity, as well as proteinuria. Results The statistical analysis among the three groups revealed that SII was significantly different in all three groups (p < 0.001). Moreover, within the SLE cohort, patients with proteinuria had significantly higher SII levels compared to those without proteinuria (p = 0.012). Correlation analysis revealed a positive association between SII and both proteinuria and Systemic Lupus Erythematosus Disease Activity Index 2000 (r = 0.215; p = 0.011 and r = 0.186; p = 0.028, respectively). Receiver operating characteristic analysis demonstrated that SII had potential clinical value in diagnosing SLE and predicting proteinuria development. Conclusions The findings of this study suggest that SII may serve as a useful biomarker for assessing disease activity and predicting proteinuria development in patients with SLE. Further research is warranted to validate these findings and explore the utility of SII in clinical practice for monitoring disease progression and treatment response in SLE.

12 September 2025 in Medicine
Verified
Journal Article
Open access
HEHatice Eyiol
Hatice Eyiol
AEAzmi Eyiol
Azmi Eyiol
AŞAhmet Taha Şahin
Ahmet Taha Şahin
Acute pericarditis is a sudden, typically noninfectious inflammation of the membrane surrounding the heart. It can arise from various causes, including viral infections, autoimmune diseases, cancer, trauma, or medications. This study aimed to evaluate the prognostic significance of the Pan-Immune-Inflammatory Value (PIV) and the hemoglobin, albumin, lymphocyte, and platelet (HALP) score in predicting disease severity, recurrence, and prognosis in patients with acute pericarditis. A retrospective cohort study was conducted, including 281 patients diagnosed with acute pericarditis between 2014 and 2023. Data on hemoglobin, albumin, neutrophil, monocyte, lymphocyte, and platelet levels, as well as clinical characteristics, treatment outcomes, and recurrence status, were extracted from hospital records. The PIV was calculated using the formula: neutrophil count (10³/mL) × monocyte percentage (%) × platelet count (10⁹/L)/lymphocyte count (10³/mL). The HALP score was determined as hemoglobin (g/L) × albumin (g/L) × lymphocyte count (10³/mL)/platelet count (10⁹/L). Statistical analyses were performed to evaluate the associations between these biomarkers and clinical outcomes. PIV was significantly higher in patients with pericardial effusion, pericardial friction rub, and persistent chest pain at 15-day follow-up ( P = .003). Patients with hypertension, hyperlipidemia, and recent infections showed elevated PIV values, indicating more severe disease and a higher likelihood of recurrence. HALP score was significantly lower in patients with pericardial effusion and in nonsmokers. HALP score was significantly higher in patients with electrocardiography changes. PIV emerged as a stronger predictor of pericarditis severity, prognosis, and recurrence compared to the HALP score. The combined use of both markers may enhance the assessment of disease severity and prognosis, offering valuable insights for clinical decision-making in pericarditis management. Further studies are needed to validate these findings.

1 December 2020 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
YAYakup Alsancak
Yakup Alsancak
AŞAhmet Taha Şahin
Ahmet Taha Şahin
AGAhmet seyfeddin Gürbüz
Ahmet seyfeddin Gürbüz
ASAhmet Lütfü Sertdemir
Ahmet Lütfü Sertdemir
AIAbdullah Icli
Abdullah Icli
MDMehmet Akif Duzenli
Mehmet Akif Duzenli
SUMMARY OBJECTIVE: Different parameters on electrocardiograms (ECG) have been investigated to predict arrhythmia and mortality in patients with acute pulmonary embolism (APE). The acute effect of thrombolytic therapy (TT) on these parameters has not been investigated yet. METHODS: We examined the data of 83 patients who were evaluated as high-risk APE and discharged from the hospital after TT. First, the high-risk APE patients’ ECGs were compared with healthy control subjects (n = 55). After their admission and 24 hours later, the ECGs of patients with APE were compared. Heart rate, P-wave morphology, QRS duration, QT distance, Tp-e, and the index of cardiac electrophysiological balance (iCEB) were analyzed. RESULTS: Although P maximum was not different between the groups’ ECGs, heart rate, QT, QTc (corrected QT) interval, Tp-e intervals, Tp-e/QT ratio, and P wave dispersion were significantly higher in the APE group ( P values < 0.031). iCEB or iCEBc (corrected iCEB) values were lower in APE group ( P < 0.001). After TT, we determined a decrease in heart rate, Tp-e interval, and Tp-e/QT ratio ( P < 0.001). Although we detected a decrease in the QT and QTc interval and QT dispersion (QTd), QTd had no statistical significance (respectively P -value 0.013, 0.029, and 0.096). The iCEB and iCEBc levels were lower after TT ( P -value was 0.035 and 0.044 respectively). CONCLUSION: The QT, QTc, Tp-e interval, Tp-e/QTc ratio, iCEB, and iCEBc values significantly decreased after TT. It may be thought that effective TT causes partial improvement in ventricular repolarization in an early period.

19 January 2024 in Medicine
Verified
Journal Article
Open access
ASAhmet Lütfü Sertdemir
Ahmet Lütfü Sertdemir
AŞAhmet Taha Şahin
Ahmet Taha Şahin
MDMustafa Duran
Mustafa Duran
MCMUSTAFA CELİK
MUSTAFA CELİK
STSefa Tatar
Sefa Tatar
YAYakup Alsancak
Yakup Alsancak
Background: Despite advances in the diagnosis and treatment of ankylosing spondylitis (AS), the risk of cardiovascular complications in AS patients is still higher than in the general population. Macrophages are at the intersection of the basic pathogenetic processes of AS and atherosclerosis. Although syndecan-4 (SDC4) mediates a variety of biological processes, the role of SDC4 in macrophage-mediated atherogenesis in AS patients remains unclear. Herein, we aimed to investigate the role of SDC4 in subclinical atherosclerosis in AS patients. Methods: Subjects were selected from eligible AS patients and control subjects without a prior history of AS who were referred to the rheumatology outpatient clinics. All participants’ past medical records and clinical, and demographic characteristics were scanned. In addition, carotid intima-media thickness (CIMT) measurement and disease activity index measurement were applied to all patients. Results: According to our data, serum SDC4 level was significantly higher among AS patients compared with the control group (6.7 [1.5–35.0] ng/mL vs 5.1 [0.1–12.5] ng/mL, P < .001). The calculated CIMT was also significantly higher in AS patients than in the control group (0.6 [0.3–0.9] mm vs 0.4 (0.2–0.7), P < .001]. Additionally, serum C-reactive protein level and SDC4 level were independent predictors of AS and strongly associated with CIMT. Linear regression analysis showed that serum SDC4 level was the best predictor of CIMT (P = .004). Conclusion: Our data indicate that serum SDC4 levels provide comprehensive information about the clinical activity of the disease and subclinical atherosclerosis in AS patients.